Mylan Expects McCain/Schumer To Move In Current Session Of Congress
Executive Summary
Mylan expects legislative efforts for a Waxman/Hatch "fix" via the McCain/Schumer bill to move in the current session of Congress
You may also be interested in...
Bristol De-Lists ABI Taxol Patent Under Settlement With Ivax
Bristol-Myers Squibb is de-listing the American BioSciences paclitaxel patent that threatened the continued marketing of generic versions of Taxol
Bristol De-Lists ABI Taxol Patent Under Settlement With Ivax
Bristol-Myers Squibb is de-listing the American BioSciences paclitaxel patent that threatened the continued marketing of generic versions of Taxol
PDUFA III Or Waxman/Hatch II?: Payors Urge Fix For Generic “Loopholes”
General Motors is among payors urging Congress to address Waxman/Hatch "loophole" legislation as part of the FDA user fee reauthorization bill